SINT vs. DRIO, COCH, OSRH, TMDIF, QTI, FEMY, XAIR, RVP, PETV, and CLGN
Should you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include DarioHealth (DRIO), Envoy Medical (COCH), OSR (OSRH), Titan Medical (TMDIF), QT Imaging (QTI), Femasys (FEMY), Beyond Air (XAIR), Retractable Technologies (RVP), PetVivo (PETV), and CollPlant Biotechnologies (CLGN). These companies are all part of the "medical equipment" industry.
Sintx Technologies vs. Its Competitors
DarioHealth (NASDAQ:DRIO) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.
33.4% of DarioHealth shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 11.2% of DarioHealth shares are held by insiders. Comparatively, 0.0% of Sintx Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
In the previous week, Sintx Technologies had 1 more articles in the media than DarioHealth. MarketBeat recorded 2 mentions for Sintx Technologies and 1 mentions for DarioHealth. Sintx Technologies' average media sentiment score of 0.75 beat DarioHealth's score of 0.63 indicating that Sintx Technologies is being referred to more favorably in the news media.
DarioHealth currently has a consensus target price of $2.00, indicating a potential upside of 181.65%. Sintx Technologies has a consensus target price of $28.00, indicating a potential upside of 740.84%. Given Sintx Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Sintx Technologies is more favorable than DarioHealth.
DarioHealth has a net margin of -159.80% compared to Sintx Technologies' net margin of -483.85%. DarioHealth's return on equity of -65.81% beat Sintx Technologies' return on equity.
DarioHealth has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500. Comparatively, Sintx Technologies has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500.
Sintx Technologies has lower revenue, but higher earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
DarioHealth beats Sintx Technologies on 9 of the 16 factors compared between the two stocks.
Get Sintx Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sintx Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:SINT) was last updated on 7/2/2025 by MarketBeat.com Staff
Free SINT Stock Alerts